Proposing a mechanism of action for ataluren

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 44, 2016, Pages 12353-12355

  Siddiqui, Nadeem ^a,b   Sonenberg, Nahum ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATALUREN; MESSENGER RNA; TOBRAMYCIN; TRANSFER RNA; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; OXADIAZOLE DERIVATIVE;

CODON; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; NONSENSE MUTATION; NOTE; PREMATURE TERMINATION CODON; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RNA TRANSLATION; HUMAN;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; OXADIAZOLES;

EID: 84993929859     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1615548113     Document Type: Note

References (16)

1. Carroll L (1865) Alice's Adventures in Wonderland (Macmillan, London), Chap 11.
2. Celik A, Kervestin S, Jacobson A (2015) NMD: At the crossroads between translation termination and ribosome recycling. Biochimie 114:2-9.
3. Behm-Ansmant I, et al. (2007) mRNA quality control: An ancient machinery recognizes and degrades mRNAs with nonsense codons. FEBS Lett 581(15):2845-2853.
4. Kellermayer R (2006) Translational readthrough induction of pathogenic nonsense mutations. Eur J Med Genet 49(6):445-450.
5. Krawczak M, et al. (2000) Human gene mutation database - a biomedical information and research resource. Hum Mutat 15(1):45-51.
6. Culbertson MR (1999) RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. Trends Genet 15(2):74-80.
7. Mort M, Ivanov D, Cooper DN, Chuzhanova NA (2008) A meta-analysis of nonsense mutations causing human genetic disease. Hum Mutat 29(8):1037-1047.
8. Welch EM, et al. (2007) PTC124 targets genetic disorders caused by nonsense mutations. Nature 447(7140):87-91.
9. Hirawat S,etal. (2007)Safety,tolerability,and pharmacokinetics of PTC124,a nonaminoglycoside nonsense mutation suppressor,following single- and multiple-dose administration to healthy male and female adult volunteers. J Clin Pharmacol 47(4):430-444.
10. Ryan NJ (2014) Ataluren: First global approval. Drugs 74(14):1709-1714.
11. Roy B, et al. (2016) Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression. Proc Natl Acad Sci USA 113:12508-12513.
12. Roy B, Leszyk JD, Mangus DA, Jacobson A (2015) Nonsense suppression by near-cognate tRNAs employs alternative base pairing at codon positions 1 and 3. Proc Natl Acad Sci USA 112(10):3038-3043.
13. Auld DS, et al. (2010) Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci USA 107(11):4878-4883.
14. Auld DS, Thorne N, Maguire WF, Inglese J (2009) Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci USA 106(9):3585-3590.
15. Salian S, et al. (2012) Structure-activity relationships among the kanamycin aminoglycosides: Role of ring I hydroxyl and amino groups. Antimicrob Agents Chemother 56(12):6104-6108.
16. He F, Jacobson A (2015) Nonsense-mediated mRNA decay: Degradation of defective transcripts is only part of the story. Annu Rev Genet 49:339-366.